Koyfin Home > Directory > Health Care > Amicus Therapeutics > Total Revenue

Amicus Therapeutics Total Revenue Chart (FOLD)

Amicus Therapeutics annual/quarterly Total Revenue from 2007 to 2018. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
  • Amicus Therapeutics Total Revenue for the last 12 months ending September 09, 2018 was $73m a 49.64% increase of 36m year over year
  • Amicus Therapeutics Annual Total Revenue for 2017 was $37m a 86.57% increase of 32m from 2016
  • Amicus Therapeutics Annual Total Revenue for 2016 was $5m a 75.31% increase of 4m from 2015
  • Amicus Therapeutics Annual Total Revenue for 2014 was $1m a 70.34% increase of 1m from 2013
Other Income Statement Metrics:
  • Amicus Therapeutics EBITDA for the quarter ending December 12, 2018 was $-68m a 20.09% decrease of -14m year over year
  • Amicus Therapeutics Net Income for the quarter ending December 12, 2018 was $-78m a 36.07% decrease of -28m year over year
View Chart On Koyfin

Quarterly FOLD Total Revenue Data

09/2018$21m
06/2018$21m
03/2018$17m
12/2017$15m
09/2017$11m
06/2017$7m
03/2017$4m
12/2016$3m
09/2016$2m
09/2014$0m

Annual FOLD Total Revenue Data

2017$37m
2016$5m
2014$1m
2013$0m
2012$18m
2011$21m
2010$1m
2009$64m
2008$15m
2007$2m